Primary sclerosing cholangitis: Patients with a rising alkaline phosphatase at annual follow-up

被引：4
|
作者：
Charatcharoenwitthaya, Punchai [1 ]
Lindor, Keith D. [1 ]
机构：
[1] Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Coll Med, Rochester, MN 55905 USA
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2007年 / 5卷 / 01期
关键词：
D O I：
10.1016/j.cgh.2006.10.021
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：32 / 36
页数：5
相关论文
共 50 条
  • [41] Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value
    de Vries, Elisabeth M. G.
    Wang, Junfeng
    Leeflang, Mariska M. G.
    Boonstra, Kirsten
    Weersma, Rinse K.
    Beuers, Ulrich H.
    Geskus, Ronald B.
    Ponsioen, Cyriel Y.
    LIVER INTERNATIONAL, 2016, 36 (12) : 1867 - 1875
  • [42] Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: A comparison of the alkaline phosphatase and immunofluorescent techniques
    Bansi, DS
    Bauducci, M
    Bergqvist, A
    Boberg, K
    Broome, U
    Chapman, R
    Fleming, K
    Jorgensen, R
    Lindor, K
    Rosina, F
    Schrumpf, E
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1997, 9 (06) : 575 - 580
  • [43] Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis
    Rupp, C.
    Roessler, A.
    Halibasic, E.
    Sauer, P.
    Weiss, K. -H.
    Friedrich, K.
    Wannhoff, A.
    Stiehl, A.
    Stremmel, W.
    Trauner, M.
    Gotthardt, D. N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (11-12) : 1292 - 1301
  • [44] Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF
    Fossdal, Guri
    Mjelle, Anders B.
    Wiencke, Kristine
    Bjork, Ida
    Gilja, Odd Helge
    Folseraas, Trine
    Karlsen, Tom Hemming
    Rosenberg, William
    Giil, Lasse M.
    Vesterhus, Mette
    JHEP REPORTS, 2021, 3 (05)
  • [45] PRIMARY SCLEROSING CHOLANGITIS (PSC), A FOLLOW-UP-STUDY OF THE YALE EXPERIENCE
    FIARMAN, G
    GARCIATSAO, G
    RODRIGUEZPEREZ, F
    WEST, AB
    BOYER, JL
    HEPATOLOGY, 1993, 18 (04) : A212 - A212
  • [46] Hepatobiliary sarcoidosis presenting as sclerosing cholangitis: Long-term follow-up
    Maambo, Emily
    Brett, Allan S.
    Vasudeva, Rajeev
    Burns, Ronald G.
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (12) : 3363 - 3365
  • [47] Primary sclerosing cholangitis treated by endoscopic biliary dilation: Review and long-term follow-up evaluation
    Johnson G.K.
    Saeian K.
    Geenen J.E.
    Current Gastroenterology Reports, 2006, 8 (2) : 147 - 155
  • [48] Hepatobiliary Sarcoidosis Presenting as Sclerosing Cholangitis: Long-Term Follow-Up
    Emily Maambo
    Allan S. Brett
    Rajeev Vasudeva
    Ronald G. Burns
    Digestive Diseases and Sciences, 2007, 52 : 3363 - 3365
  • [49] Long-term follow-up of a multicenter, randomized controlled trial of ursodeoxycholic acid in primary sclerosing cholangitis
    Hilscher, Moira
    Tabibian, James H.
    Enders, Felicity B.
    Carey, Elizabeth J.
    Lindor, Keith D.
    HEPATOLOGY, 2015, 62 : 509A - 509A
  • [50] Serum cholestanol - A new sensitive method to detect and follow-up progression of cholestasis in primary sclerosing cholangitis (PSC).
    Farkkila, MA
    Karvonen, AL
    Pikkarainen, P
    Nurmi, H
    Nuutinen, H
    Miettinen, TA
    GASTROENTEROLOGY, 1996, 110 (04) : A1189 - A1189
12345